Organogenesis Holdings Inc. (ORGO) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
ORGO currently has 128M outstanding shares. with moderate dilution risk from 57.9M authorized shares representing 45.3% potential dilution. The company has minimally diluted shareholders by 1.73% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 127.8M shares outstanding |
130M | 58M |
| Nov 06, 2025 |
10-Q filing | 126.9M shares outstanding |
130M | 59M |
| Aug 07, 2025 |
10-Q filing | 126.9M shares outstanding |
130M | 59M |
| May 08, 2025 |
10-Q filing | 126.3M shares outstanding |
130M | 59M |
| Feb 27, 2025 |
10-K filing | 131.7M shares outstanding |
130M | 54M |
| Dec 19, 2024 |
S-3 filing: The filing relates to the resale from time to time by the Selling Stockholders of up to 130,000 shares of Series A Preferred Stock and 34,285,653 shares of Class A Common Stock issuable upon conversion of the Preferred Shares. |
130M | 53M |
| Dec 02, 2024 |
8-K filing: Organogenesis Holdings Inc. entered into a stock repurchase agreement with the GN 2016 Family Trust to repurchase 500,000 shares of the Company's Class A common stock at a purchase price of $4.057 per share, with the repurchase expected to close on or around December 3, 2024. ($2.03M proceeds) |
130M | 19M |
| Nov 12, 2024 |
10-Q filing | 132.6M shares outstanding |
130M | 19M |
| Aug 08, 2024 |
S-3 filing: The filing is an S-3 form for a shelf registration of Class A Common Stock, Preferred Stock, and Debt Securities, with a total offering amount of $250,000,000 and 50,000,000 shares of Class A common stock offered by selling securityholders. |
130M | 20M |
| Aug 08, 2024 |
10-Q filing | 132.6M shares outstanding |
130M | 19M |
| May 09, 2024 |
10-Q filing | 131.9M shares outstanding |
130M | 0 |
| Feb 29, 2024 |
10-K filing | 131.2M shares outstanding |
130M | 0 |
| Nov 09, 2023 |
10-Q filing | 131.3M shares outstanding |
130M | 0 |
| Aug 09, 2023 |
10-Q filing | 131.3M shares outstanding |
130M | 0 |
| May 10, 2023 |
10-Q filing | 131.1M shares outstanding |
130M | 0 |
| Mar 01, 2023 |
10-K filing | 130.1M shares outstanding |
130M | 0 |
| Nov 09, 2022 |
10-Q filing | 130.9M shares outstanding |
130M | 0 |
| Aug 09, 2022 |
10-Q filing | 129.6M shares outstanding |
130M | 0 |
| May 10, 2022 |
10-Q filing | 128.8M shares outstanding |
130M | 0 |
| Mar 01, 2022 |
10-K filing | 128.3M shares outstanding |
130M | 0 |
| Nov 09, 2021 |
10-Q filing | 128.5M shares outstanding |
130M | 0 |
| Aug 09, 2021 |
10-Q filing | 128.2M shares outstanding |
130M | 0 |
| May 11, 2021 |
10-Q filing | 127.9M shares outstanding |
130M | 0 |
| Mar 16, 2021 |
10-K filing | 0.7M shares outstanding |
730K | 100M |
| Nov 09, 2020 |
10-Q filing | 91.3M shares outstanding |
91M | 10M |
| Oct 16, 2020 |
S-1 filing: This is an S-1 filing related to the company's Class A common stock listing on Nasdaq and a previous underwritten public offering. |
91M | 10M |
| Aug 10, 2020 |
10-Q filing | 91.3M shares outstanding |
91M | 0 |
| May 11, 2020 |
10-Q filing | 104.9M shares outstanding |
100M | 0 |
| Mar 09, 2020 |
10-K filing | 105.4M shares outstanding |
110M | 0 |